Early Discharge of Patients With Venous Thromboembolism: Implications Regarding Therapy

被引:9
作者
Stein, Paul D. [1 ]
Hull, Russell D. [2 ]
Matta, Fadi [1 ]
Yaekoub, Abdo Y. [3 ]
机构
[1] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] St Joseph Mercy Oakland Hosp, Dept Med, Pontiac, MI USA
关键词
pulmonary embolism; deep venous thrombosis; venous thromboembolism; heparin; warfarin; hospitalization; early discharge; ACUTE PULMONARY-EMBOLISM; HOSPITAL STAY; HEPARIN; THROMBOSIS; WARFARIN; MONOTHERAPY; ENOXAPARIN; LENGTH;
D O I
10.1177/1076029609342093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this investigation is to show trends in the duration of hospitalization of patients with pulmonary embolism (PE) and deep venous thrombosis (DVT). The number of patients discharged from short-stay non-Federal hospitals throughout the United States with a primary diagnostic code for PE or DVT from 1979 through 2005 was obtained from the National Hospital Discharge Survey. By 2005, 13% of patients with PE were discharged in 1 to 2 days, 30% in 3 to 4 days, 26% in 5 to 6 days, and 31% in >= 7 days. Regarding DVT, by 2005, 26% of patients with DVT were discharged in 1 to 2 days, 34% were discharged in 3 to 4 days, 20% were discharged in 5 to 6 days, and 19% were discharged in >= 7 days. The data indicate that large proportions of patients with a primary diagnosis of PE and of DVT are being discharged before adequate heparin can be administered and before warfarin can become antithrombotic. Others have reported an increased mortality among patients with PE discharged in <= 4 days. If patients are to be discharged before adequate heparin can be administered, outpatient treatment with low-molecular-weight heparin (LMWH) for at least 5 days and until the international normalized ratio (INR) is >= 2.0 for 24 hours is recommended or extended outpatient treatment with LMWH may be considered.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 27 条
[1]   Length of hospital stay and postdischarge mortality in patients with pulmonary embolism [J].
Aujesky, Drahomir ;
Stone, Roslyn A. ;
Kim, Sunghee ;
Crick, Elsa J. ;
Fine, Michael J. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (07) :706-712
[2]   COMPARATIVE EFFECTS OF DICOUMAROL, TROMEXAN, AND HEPARIN ON THROMBUS PROPAGATION [J].
CAREY, LC ;
WILLIAMS, RD .
ANNALS OF SURGERY, 1960, 152 (05) :919-922
[3]  
GALLUS A, 1986, LANCET, V2, P1293
[4]   Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy [J].
Harrison, L ;
Johnston, M ;
Massicotte, MP ;
Crowther, M ;
Moffat, K ;
Hirsh, J .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (02) :133-136
[5]   HEPARIN FOR 5 DAYS AS COMPARED WITH 10 DAYS IN THE INITIAL TREATMENT OF PROXIMAL VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
PANJU, AA ;
BRILLEDWARDS, P ;
GINSBERG, JS ;
HIRSH, J ;
MARTIN, GJ ;
GREEN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1260-1264
[6]   Treatment of acute pulmonary embolism as outpatients or following early discharge A systematic review [J].
Janjua, Muhammad ;
Badshah, Aaref ;
Matta, Fadi ;
Danescu, Liviu G. ;
Yaekoub, Abdo Y. ;
Stein, Paul D. .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (05) :756-761
[7]   Monotherapy with enoxaparin for the prevention of recurrent venous thromboembolism [J].
Jimenez Castro, David ;
Diaz, Gerna ;
Marti, David ;
Escobar, Carlos ;
Ortega, Javier ;
Garcia-Rull, Sergio ;
Picher, Joaquin ;
Sueiro, Antonio .
BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (02) :173-177
[8]   Antithrombotic therapy for venous thromboembolic disease [J].
Kearon, Clive ;
Kahn, Susan R. ;
Agnelli, Giancarlo ;
Goldhaber, Samuel ;
Raskob, Gary E. ;
Comerota, Anthony J. .
CHEST, 2008, 133 (06) :454S-545S
[9]   THE EPIDEMIOLOGY OF DIAGNOSED PULMONARY-EMBOLISM AND DEEP VENOUS THROMBOSIS IN THE ELDERLY [J].
KNIFFIN, WD ;
BARON, JA ;
BARRETT, J ;
BIRKMEYER, JD ;
ANDERSON, FA .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (08) :861-866
[10]   Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home [J].
Koopman, MMW ;
Prandoni, P ;
Piovella, F ;
Ockelford, PA ;
Brandjes, DPM ;
vanderMeer, J ;
Gallus, AS ;
Simonneau, G ;
Chesterman, CH ;
Prins, MH ;
Bossuyt, PMM ;
deHaes, H ;
vandenBelt, AGM ;
Sagnard, L ;
DAzemar, P ;
Buller, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :682-687